GlassScriptPhysician profile
David R Aronoff
NPI 1821030925
$6,148.77
in general payments reported to CMS, 2019-2025
35 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Pediatric Urology provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $206 · 2021: $1,003 · 2022: $2,646 · 2023: $884 · 2024: $851 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,659 · Consulting Fee: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,658.65 |
| Consulting Fee | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $2,010.82 | 2022-2024 | Aquabeam System |
| Boston Scientific Corporation | $1,427.58 | 2022-2025 | Ams 700 Cxr Rte Kit, Ams 700, Lithovue |
| Teleflex LLC | $675.14 | 2021-2023 | Urolift |
| 180 Medical, INC. | $274.34 | 2020-2025 | Gentlecath |
| Endo Pharmaceuticals INC. | $218.58 | 2019-2024 | Xiaflex, Aveed, Edex |
| Intuitive Surgical, INC. | $209.50 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $139.07 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $102.51 | 2023 | |
| Myriad Genetic Laboratories, INC. | $97.70 | 2022-2023 | Prolaris |
| Endo USA, INC. | $92.29 | 2024-2025 | Xiaflex, Aveed |
| Amgen INC. | $81.57 | 2019-2021 | |
| Neotract INC. | $73.86 | 2020 | |
| Dendreon Pharmaceuticals LLC | $72.26 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $59.27 | 2023-2025 | Pylarify |
| Medtronic, INC. | $55.77 | 2023-2024 | Interstim |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Varian Medical Systems, INC. | $55.22 | 2019 | |
| Merck Sharp & Dohme LLC | $50.98 | 2021 | |
| Olympus America INC. | $44.41 | 2022-2025 | Itind System |
| Astrazeneca Pharmaceuticals LP | $42.50 | 2023 | Lynparza |
| Janssen Biotech, INC. | $42.38 | 2020-2025 | Tremfya |
| Urogen Pharma, INC. | $35.87 | 2022-2025 | |
| Genzyme Corporation | $34.66 | 2020-2021 | |
| Blue Earth Diagnostics | $30.26 | 2021-2023 | |
| Exelixis INC. | $28.87 | 2019-2020 | |
| Coloplast Corp | $24.89 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.47 | 2025 | Lifevest |
| Edwards Lifesciences Corporation | $22.45 | 2025 | |
| Urovant Sciences INC | $19.35 | 2022 | |
| Ambu INC. | $17.12 | 2023 | |
| Abc Home Medical Supply, INC. | $17.02 | 2022 | |
| Laborie Medical Technologies Corp. | $16.63 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $15.10 | 2021 | |
| Axonics, INC. | $13.89 | 2022 | |
| Rgh Enterprises LLC | $12.98 | 2020 | |
| Myovant Sciences INC. | $11.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Aronoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.